Related Experiment Video
Updated: Nov 25, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean
Jung Yeon Seo1,2, Joong-Gon Shin1,3, Byeong Ju Youn2
1Current address: Department of Core Technology, R&D Center, LG Household & Healthcare (LG H&H), Seoul, 07795, South Korea.
Insights
The complement factor B (CFB) rs12614 variant significantly impacts chronic hepatitis B (CHB) risk in Koreans. This finding validates rs12614 as a potential causal genetic marker for CHB susceptibility.
Area of Science:
- Genetics
- Hepatology
- Immunology
Background:
- Hepatitis B virus (HBV) infection causes chronic hepatitis B (CHB) and hepatocellular carcinoma.
- Previous genome-wide association studies (GWAS) identified the complement factor B (CFB) rs12614 single nucleotide polymorphism (SNP) as associated with CHB risk.
Purpose of the Study:
- To fine-map the CFB rs12614 SNP to validate its genetic effect on CHB susceptibility in a Korean population.
- To identify potential additional causal variants around rs12614 associated with CHB.
Main Methods:
- Genotyping of 10 CFB genetic polymorphisms in 1716 individuals (955 CHB patients, 761 controls).
- Fine-mapping, linkage disequilibrium, and conditional analyses were performed.
Main Results:
- The non-synonymous variant rs12614 (Arg32Trp) showed a significant association with CHB risk (OR=0.43, P=5.91×10⁻¹⁰).
- rs12614 demonstrated an independent genetic effect on CHB susceptibility.
- Higher genetic risk scores (GRSs) were observed in CHB patients compared to controls, with increased odds ratios correlating with cumulative GRS.
Conclusions:
- The rs12614 variant has a significant genetic effect on CHB risk in the Korean population.
- rs12614 is a potential causal genetic variant for CHB susceptibility.
Background:
Hepatitis B is known to cause several forms of liver diseases including chronic hepatitis B (CHB), and hepatocellular carcinoma. Previous genome-wide association study of CHB risk has demonstrated that rs12614 of complement factor B (CFB) was significantly associated with CHB risk. In this study, fine-mapping study of previously reported GWAS single nucleotide polymorphism (SNP; CFB rs12614) was performed to validate genetic effect of rs12614 on CHB susceptibility and identify possible additional causal variants around rs12614 in a Korean population. This association study was conducted in order to identify genetic effects of CFB single nucleotide polymorphisms (SNPs) and to identify additional independent CHB susceptible causal markers within a Korean population.
Methods:
A total of 10 CFB genetic polymorphisms were selected and genotyped in 1716 study subjects comprised of 955 CHB patients and 761 population controls.
Results:
A non-synonymous variant, rs12614 (Arg32Trp) in exon2 of CFB, had significant associations with risk of CHB (odds ratio = 0.43, P = 5.91 × 10- 10). Additional linkage disequilibrium and conditional analysis confirmed that rs12614 had independent genetic effect on CHB susceptibility with previously identified CHB markers. The genetic risk scores (GRSs) were calculated and the CHB patients had higher GRSs than the population controls. Moreover, OR was found to increase significantly with cumulative GRS.
Conclusions:
rs12614 showed significant genetic effect on CHB risk within the Korean population. As such rs12614 may be used as a possible causal genetic variant for CHB susceptibility.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Leaky Scanning
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

